The clinical use of levodopa in the treatment of Parkinson's disease.
D000208:Acute Disease; D000328:Adult; D000367:Age Factors; D000368:Aged; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D002140:California; D002986:Clinical Trials as Topic; D004295:Dihydroxyphenylalanine / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D004185:Disability Evaluation; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009519:New York City; D010300:Parkinson Disease / Q000188:drug therapy* / Q000209:etiology; D010301:Parkinson Disease, Postencephalitic / Q000188:drug therapy; D012737:Sex Factors; D013997:Time Factors
D000978:Antiparkinson Agents; D004295:Dihydroxyphenylalanine